CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4734)
Astex is a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system.
Company (Acquired)
Phone: +44 (0)1223 226200
436 Cambridge Science Park
Cambridge, CB4 0QA
England, United Kingdom
| Total Funding | Date of Last Funding | |
|---|---|---|
| Astex Pharmaceuticals | $0M | Jul 21, 2011 |
| Melinta Therapeutics | $381.7M | Nov 6, 2017 |
| Archemix | $116.5M | Apr 6, 2004 |
| See all 25 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Bicyclic heterocycle compounds and their uses in therapy | Jan 20, 2017 | May 29, 2018 | Patent |
| Hydroxybenzamide derivatives and their use as inhibitors of hsp90 | Aug 25, 2014 | Mar 13, 2018 | Patent |
| Quinoxaline derivatives useful as fgfr kinase modulators | Mar 26, 2015 | Feb 27, 2018 | Patent |
| Substituted quinoxalines as fgfr kinase inhibitors | Aug 03, 2015 | Jan 02, 2018 | Patent |
| Pyrazolyl quinoxaline kinase inhibitors | Apr 28, 2016 | Dec 26, 2017 | Patent |
